Drugs / SVF
last change Feb 2024 re-read 3 minutes ago

SVF

Developed for
arthropathy, erosive
Investigated by
University Hospital, Rouen

Trials 1

202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT05708430 Feb 2024 → Dec 2026 expected arthropathy, erosive University Hospital, Rouen Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SVF ClinicalTrials.gov intervention name — accepted as the source's own label NCT05708430 ↗
Route Other “Intra-articular injection of autologous cells from the stromal vascular fraction derived from adipose tissue” NCT05708430 ↗